Pulse Biosciences, Inc.
US ˙ NasdaqCM ˙ US74587B1017

SecurityPLSE / Pulse Biosciences, Inc.
InsiderDarrin Uecker
This page shows the track record and history of UECKER DARRIN insider trades in Pulse Biosciences, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Darrin Uecker in PLSE / Pulse Biosciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PLSE / Pulse Biosciences, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Darrin Uecker in PLSE / Pulse Biosciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-06-13 15,000 15.9800 15,000 15.9800 239,700 91 14.5200 -21,900 -9.14
2025-06-12 15,000 16.4000 15,000 16.4000 246,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PLSE / Pulse Biosciences, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-18 2025-09-17 4 UECKER DARRIN PLSE Common Stock M - Exercise D 4.0000 100,000 400 284,406
2025-09-18 2025-09-17 4 UECKER DARRIN PLSE Common Stock M - Exercise D 4.0000 61,534 246 184,406
2025-09-18 2025-09-17 4 UECKER DARRIN PLSE Common Stock S - Sale D 16.2100 -20,000 -324 122,872
2025-09-18 2025-09-17 4 UECKER DARRIN PLSE Common Stock M - Exercise D 4.0000 20,000 80 142,872
2025-09-18 2025-09-16 4 UECKER DARRIN PLSE Common Stock S - Sale D 16.2800 -25,000 -407 122,872
2025-09-18 2025-09-16 4 UECKER DARRIN PLSE Common Stock M - Exercise D 4.0000 25,000 100 147,872
2025-09-15 2025-09-15 4 UECKER DARRIN PLSE Common Stock S - Sale D 15.7700 -25,000 -394 122,872
2025-09-15 2025-09-15 4 UECKER DARRIN PLSE Common Stock M - Exercise D 4.0000 25,000 100 147,872
2025-09-15 2025-09-12 4 UECKER DARRIN PLSE Common Stock S - Sale D 14.3200 -25,000 -358 122,872
2025-09-15 2025-09-12 4 UECKER DARRIN PLSE Common Stock M - Exercise D 4.0000 25,000 100 147,872
2025-09-15 2025-09-11 4 UECKER DARRIN PLSE Common Stock S - Sale D 14.7800 -25,000 -370 122,872
2025-09-15 2025-09-11 4 UECKER DARRIN PLSE Common Stock M - Exercise D 4.0000 25,000 100 147,872
2025-06-16 2025-06-13 4 UECKER DARRIN PLSE Common Stock S - Sale D 15.9800 -15,000 -240 122,872
2025-06-16 2025-06-12 4 UECKER DARRIN PLSE Common Stock S - Sale D 16.4000 -15,000 -246 137,872
2023-07-06 2023-06-12 4/A UECKER DARRIN PLSE Common Stock X - Other D 2.0500 7,365 15 148,941
2023-06-13 2023-06-12 4 UECKER DARRIN PLSE Common Stock X - Other D 2.0500 7,365 15 877,636
2022-06-10 2022-06-09 4 UECKER DARRIN PLSE Common Stock X - Other D 7,365 137,376
2021-03-24 2021-03-22 4 UECKER DARRIN PLSE Stock Option (right to buy) A - Award D 24.03 54,750 54,750
2021-03-24 2021-02-23 4 UECKER DARRIN PLSE Stock Option (right to buy) A - Award D 10.66 37,500 37,500
2021-01-26 2021-01-25 4 UECKER DARRIN PLSE Warrant (right to buy) X - Other D 7.01 -1,284 0
2021-01-26 2021-01-25 4 UECKER DARRIN PLSE Common Stock X - Other D 7.0100 1,284 9 127,893
2020-06-17 2020-06-15 4 UECKER DARRIN PLSE Warrant (right to buy) P - Purchase D 7.01 1,284 1,284
2020-06-17 2020-06-15 4 UECKER DARRIN PLSE Common Stock X - Other D 7.0100 8,563 60 126,609
2019-06-05 2019-06-03 4 UECKER DARRIN PLSE Common Stock F - Taxes D -36,321 118,046
2018-06-04 2018-06-01 4 UECKER DARRIN PLSE Common Stock F - Taxes D -7,168 153,981
2017-06-09 2017-06-07 4 UECKER DARRIN PLSE Stock Option (right to buy) A - Award D 30.99 195,000 195,000
2017-06-09 2017-06-07 4 UECKER DARRIN PLSE Stock Option (right to buy) A - Award D 30.99 187,286 187,286
2017-06-09 2017-06-07 4 UECKER DARRIN PLSE Common Stock A - Award D 160,974 160,974
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)